Health CanadaGeneral Alert
Updated Labelling for Antibiotic Avelox (Moxifloxacin) Regarding Rare Risk of Se...
Published: March 22, 2010Recall ID: 23982Category: generalCountry: Canada
Product Description & Identification
Updated Labelling for Antibiotic Avelox (Moxifloxacin) Regarding Rare Risk of Severe Liver Injury
Additional Source Details
| Field | Value |
|---|---|
| N I D | 23982 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/updated-labelling-antibiotic-avelox-moxifloxacin-regarding-rare-risk-severe-liver |
| Title | Updated Labelling for Antibiotic Avelox (Moxifloxacin) Regarding Rare Risk of Severe Liver Injury |
| Archived | 1 |
| Category | Drugs |
| Last updated | 2010-03-22 |
| Organization | Communications and Public Affairs Branch |